Latest Transthyretin cardiomyopathy News
ATTRibute-CM: Acoramidis Linked to Improved clinical outcomes in transthyretin amyloid cardiomyopathy
Key Points: Transthyretin amyloid cardiomyopathy develops because of mis-folded proteins infiltrating the…
Tafamidis, A Real Hope for People with Transthyretin Cardiomyopathy?
On Thursday, March 29th, Pfizer announced positive topline results from ATTR-ACT trial…